C9ORF72 in Motor System Biology and ALS
C9ORF72 in Motor System Biology and ALS
批准号:
9084666
负责人:
KEVIN C EGGAN
金额:
$45.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-15 至 2019-06-30
关键词:
AdultAllelesAmyotrophic Lateral SclerosisAnimal ModelAnimalsBiological AssayBiologyC9ORF72CellsCessation of lifeCohort AnalysisComb animal structureControl AnimalCre-LoxPDataDenervationDevelopmentDoseFundingGene TargetingGenerationsGenesGenetic TranscriptionHealthImmuneKnock-outMaintenanceModelingMotorMotor NeuronsMusMuscular AtrophyMutationNatural HistoryNerve DegenerationNeurodegenerative DisordersOrthologous GeneParalysedPathologyPatientsPhenotypePlayPreparationRodent ModelRoleSamplingSeriesSystemSystems BiologyTechniquesTechnologyTestingTherapeutic Interventionagedastrogliosiscell typedesigndrug discoverygain of functiongene productgenome editinginduced pluripotent stem cellinsightknockout animalloss of functionloss of function mutationmortalitymotor neuron degenerationmouse modelmutantprofiles in patients
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A hexanucleotide repeat expansion at C9ORF72 has recently been found in a significant fraction of patients suffering from Amyotrophic Lateral Sclerosis (ALS). However, it remains to be determined whether this mutation acts through a gain of function or loss of function mechanism. Resolving this issue is essential for long term efforts to design and implement therapies that counteract the effects of this mutation in ALS. As preliminary data, we provide evidence that heterozygous and homozygous mice harboring a loss of function mutation in the ortholog of C9ORF72 are viable, survive to adulthood and initially display motor system functionality similar to their wild type littermates. However, as heterozygous animals aged, we found they displayed a significantly increased rate of mortality. Death in heterozygous animals was associated with declining motor function and paralysis that were accompanied by muscle atrophy, denervation and motor nerve degeneration. Homozygous mutant animals displayed a similar but accelerated and quantitatively more severe phenotype. Our preliminary studies suggest that C9ORF72 serves an important dose dependent function in the long-term maintenance of the mammalian motor system. These findings support the hypothesis that reduced C9ORF72 function and haploinsufficiency resulting from the repeat expansion that many patients harbor contributes directly to the development of ALS. Here we propose three aims to increase understanding of the role that C9ORF72 plays in the biology of motor neuron degeneration. First, we will determine the extent to which features of motor neuron degeneration in mice harboring a loss of function mutation in the C9ORF72 ortholog are consistent with those observed in ALS. These studies will allow us to determine to what extent the mice we have generated might have utility as a mouse model for both mechanistic and drug discovery studies. Second, we will determine whether motor neuron degeneration in C9ORF72 ortholog mutant animals occurs through cell autonomous mechanisms in motor neurons, or is due to the non-autonomous influence of mutant immune cells. Third, we will determine the extent to which transcriptional changes found in patient derived motor neurons by the C9ORF72 repeat expansion can be explained by loss of function of the C9ORF72 gene product. If funded, our studies will provide important insight into the extent to which loss of the C9ORF72 gene product contributes to motor neuron degeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
C9ORF72 in Motor System Biology and ALS
-
批准号:9292392
-
项目类别:
-
资助金额:$45.42万
-
财政年份:2014
-
负责人:KEVIN C EGGAN
-
依托单位:
C9ORF72 in Motor System Biology and ALS
-
批准号:8925168
-
项目类别:
-
资助金额:$43.39万
-
财政年份:2014
-
负责人:KEVIN C EGGAN
-
依托单位:
Reprogramming using small molecules
-
批准号:8829869
-
项目类别:
-
资助金额:$31.55万
-
财政年份:2012
-
负责人:KEVIN C EGGAN
-
依托单位:
New hiPSC tools for astroglial-focused approaches to ALS
-
批准号:8293969
-
项目类别:
-
资助金额:$84.96万
-
财政年份:2012
-
负责人:KEVIN C EGGAN
-
依托单位:
Reprogramming using small molecules
-
批准号:8236158
-
项目类别:
-
资助金额:$31.42万
-
财政年份:2012
-
负责人:KEVIN C EGGAN
-
依托单位:
Reprogramming using small molecules
-
批准号:8448114
-
项目类别:
-
资助金额:$30.35万
-
财政年份:2012
-
负责人:KEVIN C EGGAN
-
依托单位:
Generation and Characterization of Amyotrophic Lateral Sclerosis
-
批准号:8288399
-
项目类别:
-
资助金额:$84.96万
-
财政年份:2012
-
负责人:KEVIN C EGGAN
-
依托单位:
Reprogramming using small molecules
-
批准号:8629767
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2012
-
负责人:KEVIN C EGGAN
-
依托单位:
Generation and Characterization of Amyotrophic Lateral Sclerosis
-
批准号:8488511
-
项目类别:
-
资助金额:$79.0万
-
财政年份:2012
-
负责人:KEVIN C EGGAN
-
依托单位:
Developmental Reprogramming after Nuclear Transfer
-
批准号:7209727
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2005
-
负责人:KEVIN C EGGAN
-
依托单位:
Developmental Reprogramming after Nuclear Transfer
-
批准号:7409155
-
项目类别:
-
资助金额:$30.48万
-
财政年份:2005
-
负责人:KEVIN C EGGAN
-
依托单位:
Developmental Reprogramming after Nuclear Transfer
-
批准号:7038278
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2005
-
负责人:KEVIN C EGGAN
-
依托单位:
Developmental Reprogramming after Nuclear Transfer
-
批准号:8447349
-
项目类别:
-
资助金额:$28.06万
-
财政年份:2005
-
负责人:KEVIN C EGGAN
-
依托单位:
Developmental Reprogramming after Nuclear Transfer
-
批准号:7600620
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2005
-
负责人:KEVIN C EGGAN
-
依托单位:
Developmental Reprogramming after Nuclear Transfer
-
批准号:8250264
-
项目类别:
-
资助金额:$43.38万
-
财政年份:2005
-
负责人:KEVIN C EGGAN
-
依托单位:
Developmental Reprogramming after Nuclear Transfer
-
批准号:7806462
-
项目类别:
-
资助金额:$43.24万
-
财政年份:2005
-
负责人:KEVIN C EGGAN
-
依托单位:
Developmental Reprogramming after Nuclear Transfer
-
批准号:6923279
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2005
-
负责人:KEVIN C EGGAN
-
依托单位:
Developmental Reprogramming after Nuclear Transfer
-
批准号:8056657
-
项目类别:
-
资助金额:$42.43万
-
财政年份:2005
-
负责人:KEVIN C EGGAN
-
依托单位:
Project 4: Dynamics of X chromosome inactivation
-
批准号:8206147
-
项目类别:
-
资助金额:$50.66万
-
财政年份:--
-
负责人:KEVIN C EGGAN
-
依托单位:
Project 4: Dynamics of X chromosome inactivation
-
批准号:8717681
-
项目类别:
-
资助金额:$40.67万
-
财政年份:--
-
负责人:KEVIN C EGGAN
-
依托单位:
海外基金